This Academy member benefit temporarily has been made public to allow all practitioners access to content that may assist in patient care during the national pandemic response. Click here for information on joining the Academy. 

Sodium

NA: Sodium and Blood Pressure Response Table (2010)

Click to export in Excel

 
 
NORMOTENSION
<120/80
PREHYPERTENSION
120-139 SBP and/or 80-89 DBP  
 HYPERTENSION
>140/90
 
Author, year
Blood Pressure (mmHg)
Na+ Change
Final Na Level Achieved
BP response
Na+ Change
Final Na Level Achieved
BP Response
Na+ Change
Final Na Level Achieved
BP Response
Appel, 2001
 
<145/85
N/A
N/A
N/A
N/A
N/A
N/A
↓ of -40mmol/L UNa (0.9g)
Level not specified
-4.3/-2.0
Bray, 2004
 
*Range 120-159/80-95
Mean non-HTN 120/78 to 125/81
Mean HTN 129/82 to 141/86
Intake of 50-150mmol/2100kcal (1.2 to 3.5g)
65, 107 and 142mmol
-2.2 to -5.6
Intake of 50-150mmol/2100 kcal (1.2 to 3.5g)
65, 107 and 142mmol
-2.2 to -5.6
Intake of 50-150mmol/2100kcal (1.2 to 3.5g)
65, 107 and 142mmol
-2.1 to -8.3
Cheung, 2000
 
HTN >140/90
Mean HTN 157/98
Mean NTN 117/79 (121/82 M, 113/76 F)
N/A
N/A
N/A
N/A
N/A
N/A
N/A for study design
N/A for study design
 
N/A for study design
 
Cook, 2009
 
 
<125 SBP
DBP 80-89
N/A
N/A
N/A
N/A for study design
N/A for study design
 
N/A for study design
 
N/A
N/A
N/A
Coruzzi, 2001
 
Mean 141/95
N/A
N/A
N/A
N/A
 N/A
N/A
+190mmol
Intake of 220mmol/d (5.1 g)
+5mmHg
Espeland, 2002
 
<125/75
125-134/75-80
135-144/80-84
<145/85
N/A
N/A
N/A
N/A
N/A
N/A
 
N/A for study design
N/A for study design
N/A for study design
Geleijnese, 2003
 
*HTN defined >140/90  vs. NTN <140/90
(Mean 144/88)
N/A
N/A
N/A
↓ of -77 (median) mmol/d (1.8g)
Mean urinary Na excretion: -91±52mmol/d (-2,093mg)
 
Avg -2.54/-1.96
-1.19/-1.06 (unadj)
-1.26/-1.14 (adj)
↓ of -77 (median) mmol/d (1.8g)
Mean urinary Na excretion: -91±52mmol/d (-2,093mg)
 
Avg-2.54/-1.96 -5.38/-3.85 (unadjusted)
-5.24/-3.69 (adj)
 
Geleijnese, 2004
 
HTN >140
N/A
N/A
N/A
N/A
N/A
N/A
-2.1g/d (91.3mmol)
Level not specified
Weighted ?
 -2.5/-2.0
 He, 2004
 
 
 
*NTN Mean 127/78
HTN Mean 149/94
-74mmol UNa (4.4g NaCl)
Usual NaCl intake: 154mmol (9.1g/d of salt), range 128 to 200mmol (7.5 to
11.8g/d salt); 
NaCl intake: 82mmol
(4.8g/d of salt), range: 56 to 135mmol (3.3 to 7.9g/d NaCl)
-2.03/-0.99
-74mmol UNa (4.4g NaCl)
Usual NaCl intake: 154mmol (9.1g/d of salt), range 128 to 200mmol (7.5 to
11.8g/d salt); 
NaCl intake: 82mmol
(4.8g/d of salt), range: 56 to 135mmol (3.3 to 7.9g/d NaCl)
 
 
-2.03/-0.99
78mmol UNa (4.6g NaCl) 
Usual NaCl intake: 162mmol(9.5g)/d; Range 125-191mmol (7.4-11.2g)/d 
NaCl intake: 87mmol (5.1g)/d; Range 57-125mmol (3.4-7.4g)/d (form of NaCl not specified)
 
-5.06/-2.70
He, 2003
 
*HTN and NTN not defined (meta-analysis)
-50 to -150mmol (1.2 to 3.5g)
49 to 106mmol/d
-1.8 to -3.5/-0.8 to -1.8;
-3.5 to -7/-1.7 to-3.5; -5.4 to-10.5/-2.5 to -5.3
N/A
N/A
N/A
-50 to -150mmol (1.2 to 3.5g)
49 to 106 mmol/d
-3.6 to -5.6/-1.9 to -3.2; -7.1 to -11.2/-3.9 to -5.7; -10.7 to -16.8/ -5.8 to -9.6
He, 2001
 
HTN >140/90 vs. NTN <140/90
 
Mean HTN 170/196
Mean NTN 116/74
 N/A
 N/A
 N/A
 N/A
 N/A
 N/A
-10 to -20 (0.23 to 0.46g)
340 and 330mmol/d (from 350mmol/d)
 -16.8/-5.7
He, 2000
**Inclusion: <160/80-89 Mean 122/84
 N/A
 N/A
 N/A
Level not specified
148.1mmol UNa/d at Baseline; -53.5 mmol/d UNa excretion at 18mo
 -2.7/-7.2
 N/A
 N/A
 N/A
Hu & Tian, 2001
 
 
HTN >140/90
Mean HTN 149/92 M, 151/91 F
Mean NTN 116/76 M, 117/75 F
N/A
N/A
N/A
 N/A
 N/A
 N/A
N/A for study design
N/A for study design
 
N/A for study design
 

Jessani, 2008

 

*NTN<140/90

NTN<130;Hi-Normal 130-139

200mEq (4.6g) actual ? in 24h-Na excretion 81mEq/d 20 vs. 220mEq/d; 135.2mEq/d UNa on Hi and 58.4mEq/d on Lo -1.0mmHg SBP 200mEq (4.6g) actual ? in 24h-Na excretion 91.6 mEq/d 20 vs. 220mEq/d 144.6mEq/d UNa on Hi and 53.0mEq/d on Lo -6mmHg SBP N/A N/A N/A
Johnson, 2001
 
Defined HTN as >160/90
 
NTN mean 139/78
 N/A
 N/A
N/A
90, 140, 240, 340mmol/d (1.2 to 6.9g)
 UNa (mmol/d):
61.3, 109.6, 185.0, 283.8mmol/d
+6.1/0.3, +13.7/4.0, +17.2/3.9, +16.5/5.5
 N/A
 N/A
 N/A
Jurgens, 2003
 
*Definition not specified
Not specified
<120mmol/d (2.8g)
-1.27/-0.54
N/A
N/A
N/A
Not specified
<120mmol/d vs. >150mmol/d (2.8g vs. 3.5g)
 -4.18/-1.98
Khaw, 2004
Mean BP 137/84 (define HTN >160 SBP)
N/A
N/A
N/A
N/A for study design
N/A for study design
N/A for study design
 
 N/A
N/A
N/A
Liu & Liu, 2001
 
HTN>140/90
Mean 122/73 to 135/81
N/A
N/A
N/A
N/A for study design
N/A for study design
N/A for study design
 N/A for study design
N/A for study design
N/A for study design
Radhika, 2007
 
Defined <130/85 NTN
Mean BP for HTN vs. NTN not specified
N/A
N/A
N/A
N/A for study design
N/A for study design
 
N/A for study design
 
N/A for study design
 
N/A for study design
 
N/A for study design
 
Sacks, 2001
 
*Non-HTN 120/80
Stage 1 HTN  140-159/90-95
Mean BP 134/86
N/A
N/A
N/A
50 to 150mmol/d Na on DASH and Control (1.2 to 3.5g)
UNa excretion (mmol/d): 144 vs 141; 107 vs. 106; 67 vs. 64
From 150-100:  
-2.1/1.1 vs. -1.3/-0.6; from 150 to 50: -4.6/-2.4 vs. -1.7/-1.0 DASH w/low Na ↓ SBP by 7.1mmHg 
50 to 150mmol/d Na on DASH and Control (1.2 to 3.5g)
UNa excretion (mmol/d): 144 vs 141; 107 vs. 106; 67 vs. 64
From 150-100:  
-2.1/1.1 vs. -1.3/-0.6; from 150 to 50: -4.6/-2.4 vs. -1.7/-1.0 DASH w/low Na SBP by 11.5mmHg

 

 *included in >1 category (NTN, PHTN, HTN) due to inclusion of subjects in >1 category.
** includes subjects on anti-HTN medications
 
1 mEq Na = (mg *1)/23;  mmol Na--> g Na= (mmol*23)/1000
 
At Wt Na = 23, valence = 1
 
Mw NaCl = 58.44
 
Mg Na*2.5 = mg NaCl